Financial & competing interests disclosure
Kelly Blankenship, Craig A Erickson and Christopher J McDougle are supported in part by the Division of Disability and Rehabilitative Services, Indiana Family and Social Services Administration. Craig A Erickson has received NIH grant K12 UL1 RR025761 Indiana University Clinical and Translational Sciences Institute Career Development Award. Kimberly A Stigler has received the Daniel X and Mary Freedman Fellowship in Academic Psychiatry, and the National Institute of Mental Health (NIMH) grant K23 MH082119. David J Posey and Christopher J McDougle have received NIMH grants R01 MH077600 and R01 MH072964, respectively.
Christopher J McDougle is a consultant for Bristol-Myers Squibb, has received research support from Bristol-Myers Squibb and is a member of the speakers bureau for Bristol-Myers Squibb. Craig A Erickson has received grant/research support from Bristol-Myers Squibb. Kimberly Stigler has received grant/research support from Bristol-Myers Squibb, Janssen and Eli Lilly. David J Posey is a consultant for Forest, has received grant/research support from Forest Research Institute and Eli Lilly, is a member of the speakers/advisory boards for Bristol-Myers Squibb and is a stock shareholder of Shire. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Pediatr Health. 2010;4(4):375-381. © 2010 Future Medicine Ltd.
Cite this: Aripiprazole for Irritability Associated with Autistic Disorder in Children and Adolescents Aged 6–17 Years - Medscape - Aug 01, 2010.